Gary Schwartz
Director, Case CCC · Case Western Reserve University
Credentials: · · · ·
History
- Present
Case Comprehensive Cancer Center · Case Western Reserve University
- 1986–1988
- 1985–1988
1979–1983- 1975–1979
Research
Tumour exosome integrins determine organotropic metastasis
Nature · 2015 · 4,149 citations
Guidelines for the use and interpretation of assays for monitoring autophagy
Autophagy · 2012 · 2,918 citations
Journal of Clinical Oncology · 2005 · 904 citations
- RC
55 papers · 1 as a fellow
- DK
42 papers
- MD
35 papers · 2 as a fellow
- WT
29 papers
- RM
27 papers
- CA
23 papers
- LS
23 papers
22 papers · 13 as a resident
Grants
- 2025–2030
Clinical Oncology Research Program (CORP)
National Cancer Institute · K12
Contact PI · $860.9K · Case Western Reserve University
- 1997–2030
Case Comprehensive Cancer Center Support Grant
National Cancer Institute · P30
Contact PI · $22.9M · Case Western Reserve University
- 2016–2026
Molecular Oncology Training Program
National Cancer Institute · T32
Contact PI · $1.6M · Columbia University Health Sciences
- 2014–2025
Columbia University NCI Community Oncology Research Program
National Cancer Institute · UG1
Contact PI · $6.8M · Columbia University Health Sciences
Clinical trials
- 2008–2012
PTC299 for Treatment of Advanced Cancer
Principal investigator · Terminated · Phase 1
PTC Therapeutics
- 2007–2010
Study of ADI-PEG 20 in Patients With Advanced Melanoma
Principal investigator · Completed · Phase 1, Phase 2
Ludwig Institute for Cancer Research
- 2006
Vorinostat and Alvocidib in Treating Patients With Advanced Solid Tumors
Principal investigator · Completed · Phase 1
National Cancer Institute (NCI)
- 2004–2006
Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer
Principal investigator · Completed · Phase 2
Memorial Sloan Kettering Cancer Center